Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.20.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents $ 173,025 $ 6,208
Equity method investments 581,930 498,631
Real estate 361,493 362,265
Investments 63,167 74,530
Securitization assets 121,929 123,979
Other assets 90,461 162,054
Total Assets 2,524,487 2,387,274
Liabilities:    
Accounts payable, accrued expenses and other 48,672 54,351
Credit facilities 153,074 31,199
Non-recourse debt (secured by assets of $802 million and $921 million, respectively) 633,328 700,225
Senior unsecured notes 504,724 512,153
Convertible notes 148,134 149,434
Total Liabilities 1,487,932 1,447,362
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 71,325,089 and 66,338,120 shares issued and outstanding, respectively 713 663
Additional paid in capital 1,206,225 1,102,303
Accumulated deficit (185,789) (169,786)
Accumulated other comprehensive income (loss) 11,076 3,300
Non-controlling interest 4,330 3,432
Total Stockholders’ Equity 1,036,555 939,912
Total Liabilities and Stockholders’ Equity 2,524,487 2,387,274
Government receivables    
Assets    
Receivables 259,085 263,175
Commercial receivables    
Assets    
Receivables $ 873,397 $ 896,432